Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px
Document › Details

Heidelberg Pharma AG. (8/30/22). "Press Release: Heidelberg Pharma AG Raises Approximately EUR 80 Million From Capital Measure [ Not for US, CA, et al.]". Ladenburg.

Organisation Organisation Heidelberg Pharma AG (FSE: HPHA)
  Group Heidelberg Pharma (Group)
Products Product investment banking
  Product 2 ATAC® technology
Index term Index term Heidelberg Pharma–SEVERAL: investment, 202202–202208 capital increase €79.91m with €76.24m thereof from Huadong Medicine reaching 25% shareholding
Persons Person Wimmer, Sylvia (Heidelberg Pharma 202203 Corporate Communciations formerly Wilex 201403 Corporate Communications)
  Person 2 Arnold, Katja (MC Services 201309 CIRO Executive Director before Wilex AG + CAT Consultants)
     


   
Record changed: 2023-06-05

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Heidelberg Pharma (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top